The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Second-line platinum-based chemotherapy (PBT) in patients with metastatic urothelial carcinoma (mUC) treated with first-line pembrolizumab plus enfortumab vedotin (P/EV): A single-center, retrospective study.

Junkyu  Kim

No Relationships to Disclose

Se Hoon  Park

Honoraria - Merck; Ono Pharmaceutical; Pfizer

Consulting or Advisory Role - Janssen Oncology

Research Funding - Merck Sharp & Dohme LLC (Inst)

Changgon  Kim

No Relationships to Disclose

Jiyeon  Hyeon

No Relationships to Disclose

Sung Hee  Lim

No Relationships to Disclose

Minsuk  Kwon

No Relationships to Disclose